Public company info - Innovative Pharmaceutical Biotech Ltd. , 00399.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Innovative Pharmaceutical Biotech Ltd., 00399.HK - Cash Flow 2023-03 2022-03 2021-03 2020-03 2019-03 2018-03 2017-03 2016-03 2015-03 2014-03 2013-06 2012-06 2011-06 2010-12 2010-06 2009-06 2008-06 2007-06 2006-06 2005-06
Net Cash Flow from Operating Activities -17,640 -12,335 -25,006 -36,224 -29,492 -14,920 120,035 -133,085 -35,571 -50,157 -37,436 -13,351 72,483 58,988 -39,113 -46,629 3,491 4,436 3,257 -1,181
Net Cash Flow from Return on Investments & Servicing of Finance -78 -85 -127 -137 -24,820 -24,952 -24,788 -24,602 436 5,119 5,317 5,977 1,640 0 20 -461 -923 -915 -1,599 24
　Interest Received 0 -1 0 -21 205 73 86 423 436 5,382 6,090 6,127 1,640 0 204 172 1 19 1 24
　Interest Paid -78 -84 -127 -116 -25,025 -25,025 -25,025 -25,025 0 -263 -773 -150 0 0 -184 -633 -924 -934 -1,600 0
　Dividend Received 0 0 0 0 0 0 151 0 0 0 0 0 0 0 0 0 0 0 0 0
　Dividend Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded 0 0 0 0 0 0 0 0 0 0 0 -2,209 -4,838 0 -394 -87 -33 -10 0 0
Net Cash Flow from Investing Activities 0 0 13 50,000 10,658 -676 -15,332 -1,010 33,698 -4,624 -129,243 -57,190 -201,829 -103,507 -840 -5,091 -39 -1,231 -992 -2,850
　Additions to Fixed Assets 0 0 0 0 0 0 0 -300 0 -559 -5,283 -27,913 -23,262 0 -1,330 -738 -39 -1,231 -992 -2,850
　Disposal of Fixed Assets 0 0 13 0 0 25,960 0 76 1,646 787 0 3,815 292 0 490 0 0 0 0 0
　Increase in Investments 0 0 0 0 0 -50,000 -20,122 -5,198 -71,867 -133,131 -15,041 -62,105 -103,203 0 0 0 0 0 0 0
　Decrease in Investments 0 0 0 50,000 10,658 23,364 4,790 4,412 106,458 8,279 10,854 41,745 7,257 0 0 0 0 0 0 0
　Net Cash Flow with Related Parties 16,880 9,417 13,000 -8,200 40,482 0 0 0 6 6,451 22,544 9,210 9,718 0 0 0 250 206 0 0
　Others -16,880 -9,417 -13,000 8,200 -40,482 0 0 0 -2,545 113,549 -142,317 -21,942 -92,631 -103,507 0 -4,353 -250 -206 0 0
Net Cash Flow before Financing Activities -17,718 -12,420 -25,120 13,639 -43,654 -40,548 79,915 -158,697 -1,437 -49,662 -161,362 -66,773 -132,544 -44,519 -40,327 -52,268 2,496 2,280 666 -4,007
Net Cash Flow from Financing Activities 14,999 7,382 10,700 -9,362 40,482 0 -51,003 0 6 6,451 226,170 14,117 9,718 9,718 310,401 124,643 -98 -1,946 -1,086 -138,371
　New Loans 0 0 0 0 0 0 0 0 0 0 0 4,907 0 0 0 0 0 0 43,862 0
　Loans Repayment -1,881 -2,035 -2,300 -1,162 0 0 0 0 0 0 -4,907 0 0 0 0 -25,299 -348 -2,152 -44,948 -138,371
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 131,161 0 0 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 -51,003 0 0 0 0 0 0 0 0 0 0 0 0 0
　Equity Financing 0 0 0 0 0 0 0 0 0 0 77,372 0 0 0 310,401 149,942 0 0 0 0
　Net Cash Flow with Related Parties 16,880 9,417 13,000 -8,200 40,482 0 0 0 6 6,451 22,544 9,210 9,718 0 0 0 250 206 0 0
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0 9,718 0 0 0 0 0 0
Increase(Decrease) in Cash & Cash Equivalents -2,719 -5,038 -14,420 4,277 -3,172 -40,548 28,912 -158,697 -1,431 -43,211 64,808 -52,656 -122,826 -34,801 270,074 72,375 2,398 334 -420 -142,378
Cash & Cash Equivalents at Beginning of Year 4,083 8,992 22,936 17,058 20,227 61,316 32,459 191,191 192,351 235,253 169,815 222,267 344,224 344,224 74,065 1,710 1,007 2,385 2,859 145,237
Net Cash Flow due to Change in Exchange Rate/Others -33 129 476 1,601 3 -541 -55 -35 271 309 630 204 869 406 85 -90 -1,695 -1,712 -54 0
Cash & Cash Equivalents at End of Year 1,331 4,083 8,992 22,936 17,058 20,227 61,316 32,459 191,191 192,351 235,253 169,815 222,267 309,829 344,224 73,995 1,710 1,007 2,385 2,859
Currency Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar Hong Kong Dollar
Unit Thousand Thousand Thousand Thousand Thousand Thousand Thousand Thousand Thousand
Auditor's Opinion 2 1 2 2 2 2 2 1 1 1 1 1 1 0 1 0 1 2 2 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

 
88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved